The PE Ratio as of December 2024 (TTM) for Immix Biopharma, Inc. (IMMX) is -2.58

According to Immix Biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.58. This represents a change of -31.34% compared to the average of -3.76 of the last 4 quarters.

Immix Biopharma, Inc. (IMMX) Historical PE Ratio (quarterly & annually)

How has IMMX PE Ratio performed in the past?

The mean historical PE Ratio of Immix Biopharma, Inc. over the last ten years is -10.20. The current -2.58 PE Ratio has changed 2.43% with respect to the historical average. Over the past ten years (40 quarters), IMMX's PE Ratio was at its highest in in the December 2021 quarter at -0.30. The PE Ratio was at its lowest in in the September 2020 quarter at -59.75.

Immix Biopharma, Inc. (IMMX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immix Biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immix Biopharma, Inc. (IMMX) Average PE Ratio

How has IMMX PE Ratio performed in the past?

The current PE Ratio of Immix Biopharma, Inc. (IMMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Immix Biopharma, Inc. (IMMX) PE Ratio vs. Peers

How is IMMX’s PE Ratio compared to its peers?

Immix Biopharma, Inc.’s PE Ratio is less than ZyVersa Therapeutics, Inc. (-0.00), less than Hepion Pharmaceuticals, Inc. (-0.14), less than AVROBIO, Inc. (2.07), less than eFFECTOR Therapeutics, Inc. (-0.00), less than CNS Pharmaceuticals, Inc. (-0.14), less than Navidea Biopharmaceuticals, Inc. (0.00), less than Sonnet BioTherapeutics Holdings, Inc. (-0.19), less than Freeline Therapeutics Holdings plc (0), less than Enveric Biosciences, Inc. (-1.01), less than CohBar, Inc. (-0.28), less than Elevation Oncology, Inc. (-0.13), less than Ocean Biomedical, Inc. (-0.81), less than null (-0.37),

Build a custom stock screener for Immix Biopharma, Inc. (IMMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immix Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immix Biopharma, Inc. (IMMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immix Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.